Patient, Endocrinologist, Primary Care Experiences and Expectations with GLP-1s and SGLT-2s
True trended insights, from both patients and HCPs, to bring clarity to your decision making
New Partnership Closes the Loop Between Clinical Data and Real-World Diabetes Experiences
dQ&A, the leading specialized diabetes research company, and LMC, the largest diabetes clinic in North America, announce DiaDem Insights, a breakthrough collaboration connecting…
Endocrinologist Perspectives: Oral and Injectable Therapies
dQ&A conducted another wave…
dQ&A® and CeQur Publication Featured in Clinical Diabetes
Transition to the SIP…
Findings from Diabetes Technology in Primary Care Research
In December 2022…
dQ&A® Research on Use of High Doses of Basal Insulin Published in Clinical Diabetes
In conjunction with Sanofi US…
Patients Weathering Chaos but Seeing Results When Starting Mounjaro, According to Proprietary dQ&A® Research
First Look…
Time in Range Outcomes from Six European Countries
Our European research…
Eight dQ&A® Abstracts Presented at ATTD 2023
We are excited to announce that…
dQ&A® Data on Advances in Disease-Modifying Interventions Presented at Global Congress on Cardiology
This research had four…
